Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 29

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 follows (in thousands):

SUMMARY OF ACCRUED EXPENSES 

    September
    30, 2025  
    March
    31, 2025 
  
    Research and development 
    $84  
    $360 
  
    Professional fees 
     324  
     440 
  
    Employee salaries and benefits 
     586  
     924 
  
    Deferred revenue 
     908  
     - 
  
    Goods received not invoiced 
     65  
     98 
  
    Other 
     88  
     223 
  
    Total accrued expenses
    and other current liabilities 
    $2,055  
    $2,045 

NOTE
7 BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK

In
accordance with ASC 260, Earnings Per Share, warrants that are accounted for as liabilities which are potentially dilutive have
not been included in diluted earnings per share as they would have been anti-dilutive during the six months ended September 30, 2025
and September 30, 2024.

The
following potentially dilutive securities were not included in the calculation of diluted net loss per share attributable to common stockholders
of Beyond Air because their effect would have been anti-dilutive for the periods presented:

SCHEDULE OF POTENTIAL ANTI-DILUTIVE SECURITIES 

    September
    30, 2025  
    September
    30, 2024 

    Common stock warrants 
                        2,535,395  
                        4,104,115 
  
    Common stock options 
     726,618  
     555,865 
  
    Restricted shares 
     18,265  
     30,605 
  
    Total 
     3,280,280  
     4,690,585 
  
    Anti-dilutive securities 
     3,280,280  
     4,690,585 

The Company’s pre-funded warrants were included in the calculation of diluted net loss per share.

    19

BEYOND
AIR, INC. AND SUBSIDIARIES

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE
8 COMMITMENTS AND CONTINGENCIES

License
Agreements

In
August 201